ARVN stock forecast
Our latest prediction for Arvinas, Inc.'s stock price was made on the Nov. 19, 2019 when the stock price was at 32.75$.
In the short term (2weeks), ARVN's stock price should underperform the market by -1.20%. During that period the price should oscillate between -11.32% and +12.75%.
In the medium term (3months), ARVN's stock price should underperform the market by -1.86%. During that period the price should oscillate between -23.73% and +32.66%.Get email alerts
About Arvinas, Inc.
Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110 and ARV-471. The company was founded in February 2013 and is headquartered in New Haven, CT.
At the moment the company generates 42M USD in revenues.
On its last earning announcement, the company reported a loss of -20.03$ per share.
The book value per share is 4.23$
Three months stock forecastNov. 19, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|